Product Information
IVABRADINE HCL 5 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.7713 per EA under NDC 72205033660. Its NADAC has been published 30 times since Dec 3, 2025.
Strength
5 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205033660
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213483On Market Since
4/28/2025
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 5 MG TABLET has been published 30 times since Dec 3, 2025, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7713 per EA |
|---|---|
| All-time high | $2.8731 (Dec 10, 2025) |
| All-time low | $0.7713 (Jun 17, 2026) |
| 52-week high | $2.8731 |
| 52-week low | $0.7713 |
| Median price | $0.8817 |
| Average price | $1.3062 |
| Largest weekly change | -40.9% (Feb 18, 2026) |
| Weeks tracked | 30 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 5 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.7713 per EA (NDC 72205033660), effective Jun 24, 2026.
How has the price of IVABRADINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 5 MG TABLET has declined 73.2%. It has been tracked across 30 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 5 MG TABLET?
Since Dec 3, 2025, the NADAC for IVABRADINE HCL 5 MG TABLET has ranged from a low of $0.7713 (Jun 17, 2026) to a high of $2.8731 (Dec 10, 2025), with a median of $0.8817 per EA.
Are there cheaper alternatives to IVABRADINE HCL 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as IVABRADINE HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures IVABRADINE HCL 5 MG TABLET?
IVABRADINE HCL 5 MG TABLET (NDC 72205033660) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification